Sign In
Buy RHHVF
$361.90
+1.84 (+0.512%)
At Close: Nov 17, 2025
Roche Holding AG Earnings Calls
Jun 30, 2025
$11.61 (-11.91%)
| Release date | Jun 30, 2025 |
| EPS estimate | $13.18 |
| EPS actual | $11.61 |
| EPS Surprise | -11.91% |
| Revenue estimate | 38.92B |
| Revenue actual | 40.083B |
| Revenue Surprise | 2.99% |
Mar 30, 2025
| Release date | Jul 24, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
$2.77 (-70.05%)
| Release date | Dec 31, 2024 |
| EPS estimate | $9.25 |
| EPS actual | $2.77 |
| EPS Surprise | -70.05% |
| Revenue estimate | 33.895B |
| Revenue actual | 34.837B |
| Revenue Surprise | 2.78% |
Sep 30, 2024
| Release date | Oct 23, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Roche Holding AG
Below you can see how RHHVF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2024
| Release date | Oct 23, 2024 |
| Price on release | $321.00 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 17, 2024 | $312.58 |
| Oct 18, 2024 | $312.62 |
| Oct 21, 2024 | $311.87 |
| Oct 22, 2024 | $313.74 |
| Oct 23, 2024 | $321.00 |
| Oct 24, 2024 | $321.00 |
| Oct 25, 2024 | $320.85 |
| Oct 28, 2024 | $318.01 |
| Oct 29, 2024 | $315.64 |
| 4 days before | 2.69% |
| 4 days after | -1.67% |
| On release day | 0% |
| Change in period | 0.98% |
Dec 31, 2024
Missed
| Release date | Dec 31, 2024 |
| Price on release | $280.00 |
| EPS estimate | $9.25 |
| EPS actual | $2.77 |
| EPS surprise | -70.05% |
| Date | Price |
|---|---|
| Dec 24, 2024 | $275.83 |
| Dec 26, 2024 | $281.50 |
| Dec 27, 2024 | $280.86 |
| Dec 30, 2024 | $285.00 |
| Dec 31, 2024 | $280.00 |
| Jan 02, 2025 | $273.10 |
| Jan 03, 2025 | $282.00 |
| Jan 06, 2025 | $285.00 |
| Jan 07, 2025 | $291.14 |
| 4 days before | 1.51% |
| 4 days after | 3.98% |
| On release day | 0% |
| Change in period | 5.55% |
Mar 30, 2025
| Release date | Jul 24, 2025 |
| Price on release | $333.95 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 18, 2025 | $324.56 |
| Jul 21, 2025 | $321.46 |
| Jul 22, 2025 | $317.30 |
| Jul 23, 2025 | $329.54 |
| Jul 24, 2025 | $333.95 |
| Jul 25, 2025 | $330.52 |
| Jul 28, 2025 | $327.04 |
| Jul 29, 2025 | $323.06 |
| Jul 30, 2025 | $312.38 |
| 4 days before | 2.89% |
| 4 days after | -6.46% |
| On release day | -1.03% |
| Change in period | -3.75% |
Jun 30, 2025
Missed
| Release date | Jun 30, 2025 |
| Price on release | $324.58 |
| EPS estimate | $13.18 |
| EPS actual | $11.61 |
| EPS surprise | -11.91% |
| Date | Price |
|---|---|
| Jun 24, 2025 | $323.09 |
| Jun 25, 2025 | $322.75 |
| Jun 26, 2025 | $329.00 |
| Jun 27, 2025 | $323.59 |
| Jun 30, 2025 | $324.58 |
| Jul 01, 2025 | $330.82 |
| Jul 02, 2025 | $330.00 |
| Jul 03, 2025 | $320.40 |
| Jul 07, 2025 | $323.13 |
| 4 days before | 0.460% |
| 4 days after | -0.447% |
| On release day | 1.92% |
| Change in period | 0.0105% |
Roche Holding AG Earnings Call Transcript Summary of Q2 2025
Roche reported a strong half-year performance with overall group sales increasing by 7% and a notable 10% growth in Pharmaceuticals. Their core operating profit rose by 11%, and core EPS grew by 12%. Despite a plateau in Diagnostics due to China’s pricing reforms, adjusted LOE guidance indicates strong management of anticipated impacts. Key highlights include successful approvals and strong product performance across numerous therapeutic areas. Roche is also on track to fill its late-stage pipeline with several new drugs moving into Phase III trials. Leadership emphasizes a commitment to operational efficiency, cost control, and sustained growth through innovation and strategic resource allocation.
Roche Holding AG Earnings History
Earnings Calendar
FAQ
When is the earnings report for RHHVF?
Roche Holding AG (RHHVF) has scheduled its earnings report for Jan 29, 2026 before the markets open.
What is the RHHVF price-to-earnings (P/E) ratio?
RHHVF P/E ratio as of Nov 17, 2025 (TTM) is 40.28.
What is the RHHVF EPS forecast?
The forecasted EPS (Earnings Per Share) for Roche Holding AG (RHHVF) for the first fiscal quarter 2025 is $.
What are Roche Holding AG's retained earnings?
On its balance sheet, Roche Holding AG reported retained earnings of $40.08 billion for the latest quarter ending Jun 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
